Published in Neuroscience on January 01, 1992
Neural control of the lower urinary tract. Compr Physiol (2015) 1.11
Animal models in urological disease and sexual dysfunction. Br J Pharmacol (2006) 1.03
The Role of GABAB Receptors in Morphine Self-Administration. Int J Prev Med (2013) 0.76
Sex difference in the contribution of GABAB receptors to tibial neuromodulation of bladder overactivity in cats. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest (1994) 3.51
Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol (2004) 1.81
Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 1: General considerations. Experientia (1986) 1.53
The effect of omega conotoxin GVIA, a peptide modulator of the N-type voltage sensitive calcium channels, on motor responses produced by activation of efferent and sensory nerves in mammalian smooth muscle. Naunyn Schmiedebergs Arch Pharmacol (1988) 1.47
Spontaneous release of acetylcholine from autonomic nerves in the bladder. Br J Pharmacol (2009) 1.47
Myogenic and neurogenic factors in the control of pyeloureteral motility and ureteral peristalsis. Pharmacol Rev (1998) 1.47
Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res (1990) 1.45
The nonstop transvesical cystometrogram in urethane-anesthetized rats: a simple procedure for quantitative studies on the various phases of urinary bladder voiding cycle. J Pharmacol Methods (1986) 1.43
Ruthenium red as a capsaicin antagonist. Life Sci (1991) 1.36
Further evidence for involvement of adenosine-5'-triphosphate in non-adrenergic non-cholinergic relaxation of the isolated rat duodenum. Eur J Pharmacol (1985) 1.33
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles. Neuropeptides (1998) 1.32
The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides (1997) 1.27
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther (1991) 1.24
Secretion, pain and sneezing induced by the application of capsaicin to the nasal mucosa in man. Br J Pharmacol (1988) 1.23
Role of NK1 tachykinin receptors in thermonociception: effect of (+/-)-CP 96,345, a non-peptide substance P antagonist, on the hot plate test in mice. Neurosci Lett (1991) 1.22
Analysis of factors involved in determining urinary bladder voiding cycle in urethan-anesthetized rats. Am J Physiol (1986) 1.22
Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial. J Clin Immunol (2008) 1.18
Anthracyclines: selected new developments. Curr Med Chem Anticancer Agents (2001) 1.18
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors. Eur J Pharmacol (1989) 1.17
Suitability of urethane anesthesia for physiopharmacological investigations. Part 3: Other systems and conclusions. Experientia (1986) 1.14
A potent and selective agonist for NK-2 tachykinin receptor. Peptides (1989) 1.14
The antagonism induced by ruthenium red of the actions of capsaicin on the peripheral terminals of sensory neurons: further studies. Eur J Pharmacol (1988) 1.12
Simultaneous release by bradykinin of substance P- and calcitonin gene-related peptide immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br J Pharmacol (1988) 1.11
Pharmacological evidence that at least two different non-adrenergic non-cholinergic inhibitory systems are present in the rat small intestine. Eur J Pharmacol (1986) 1.11
Prostanoids modulate reflex micturition by acting through capsaicin-sensitive afferents. Eur J Pharmacol (1988) 1.11
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res (1997) 1.10
Suitability of urethane anesthesia for physiopharmacological investigations in various systems. Part 2: Cardiovascular system. Experientia (1986) 1.10
Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol (2010) 1.08
Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br J Pharmacol (1991) 1.08
The 'efferent' function of capsaicin-sensitive nerves: ruthenium red discriminates between different mechanisms of activation. Eur J Pharmacol (1989) 1.08
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol (1999) 1.08
Characterization of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br J Pharmacol (1994) 1.04
Pharmacological evidence for the existence of two components in the twitch response to field stimulation of detrusor strips from the rat urinary bladder. J Auton Pharmacol (1985) 1.04
Low pH-induced release of calcitonin gene-related peptide from capsaicin-sensitive sensory nerves: mechanism of action and biological response. Neuroscience (1991) 1.04
A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release. Br J Pharmacol (1989) 1.04
Involvement of 5-hydroxytryptamine1A receptors in the modulation of micturition reflexes in the anesthetized rat. J Pharmacol Exp Ther (1992) 1.03
Evidence for two independent modes of activation of the 'efferent' function of capsaicin-sensitive nerves. Eur J Pharmacol (1988) 1.03
Peripheral effects of neurokinins: functional evidence for the existence of multiple receptors. J Auton Pharmacol (1987) 1.02
Tachykinin receptors and noncholinergic bronchoconstriction in the guinea-pig isolated bronchi. Am Rev Respir Dis (1991) 1.02
Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.02
Extrinsic origin of the capsaicin-sensitive innervation of rat duodenum: possible involvement of calcitonin gene-related peptide (CGRP) in the capsaicin-induced activation of intramural non-adrenergic non-cholinergic neurons. Naunyn Schmiedebergs Arch Pharmacol (1986) 1.01
Electrophysiological evidence for different release mechanism of ATP and NO as inhibitory NANC transmitters in guinea-pig colon. Br J Pharmacol (1994) 1.01
Intestinal epithelial barrier dysfunction in disease and possible therapeutical interventions. Curr Med Chem (2011) 1.01
Capsaicin-like activity of some natural pungent substances on peripheral endings of visceral primary afferents. Naunyn Schmiedebergs Arch Pharmacol (1990) 1.00
Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br J Pharmacol (1996) 1.00
Tachykinins as modulators of the micturition reflex in the central and peripheral nervous system. Regul Pept (2001) 1.00
Contractile response of the human isolated urinary bladder to neurokinins: involvement of NK-2 receptors. Eur J Pharmacol (1988) 1.00
The role of neuropeptides in the regulation of the micturition reflex. J Auton Pharmacol (1986) 1.00
Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol (1989) 1.00
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan. Eur J Pharmacol (1990) 0.99
Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol (1995) 0.99
Beneficial effect of capsaicin application to the nasal mucosa in cluster headache. Clin J Pain (1989) 0.99
Evidence that GABAA receptors mediate relaxation of rat duodenum by activating intramural nonadrenergic-noncholinergic neurones. J Auton Pharmacol (1984) 0.99
Anthracycline metabolism and toxicity in human myocardium: comparisons between doxorubicin, epirubicin, and a novel disaccharide analogue with a reduced level of formation and [4Fe-4S] reactivity of its secondary alcohol metabolite. Chem Res Toxicol (2000) 0.99
Knee osteoarthritis: a role for bradykinin? Inflamm Res (2008) 0.98
The tachykinin NK1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.98
Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Auton Nerv Syst (1992) 0.98
Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol (1990) 0.98
Simultaneous recording of vesical and urethral pressure in urethane-anesthetized rats: effect of neuromuscular blocking agents on the activity of the external urethral sphincter. J Pharmacol Methods (1991) 0.98
Prejunctional modulatory action of neuropeptide Y on peripheral terminals of capsaicin-sensitive sensory nerves. Br J Pharmacol (1989) 0.98
Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.97
Activity of SR 142801 at peripheral tachykinin receptors. Eur J Pharmacol (1995) 0.97
GABAA and GABAB receptors in detrusor strips from guinea-pig bladder dome. J Auton Pharmacol (1985) 0.97
Modulatory activity of GABAB receptors on cholinergic tone in guinea-pig distal colon. Br J Pharmacol (1985) 0.97
Capsaicin desensitization protects from antigen-induced bronchospasm in conscious guinea-pigs. Eur J Pharmacol (1987) 0.97
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors. J Auton Pharmacol (1991) 0.97
Tachykinins and calcitonin gene-related peptide as co-transmitters in local motor responses produced by sensory nerve activation in the guinea-pig isolated renal pelvis. Neuroscience (1992) 0.96
Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart. J Pharmacol Exp Ther (1991) 0.96
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. Cell Death Differ (2013) 0.96
Bradykinin-induced release of calcitonin gene-related peptide from capsaicin-sensitive nerves in guinea-pig atria: mechanism of action and calcium requirements. Neuroscience (1990) 0.96
The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of capsaicin-sensitive afferents in the guinea-pig isolated bronchus. Naunyn Schmiedebergs Arch Pharmacol (1990) 0.96
Direct evidence that capsaicin-induced plasma protein extravasation is mediated through tachykinin NK1 receptors. Eur J Pharmacol (1991) 0.96
Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol (1991) 0.96
The role of the capsaicin-sensitive innervation of the rat urinary bladder in the activation of micturition reflex. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.95
Tachykinin NK1 receptor subtypes in the rat urinary bladder. Br J Pharmacol (1994) 0.95
Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine and oesophagus. Neuroscience (1999) 0.95
Galanin: a potent modulator of excitatory neurotransmission in the human urinary bladder. Eur J Pharmacol (1987) 0.95
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. Eur J Pharmacol (2001) 0.95